Lamicone NS Tablet contains a combination of Lamivudine 150mg, Stavudine 40mg, and Nevirapine 200mg, a potent antiretroviral therapy (ART) formulation indicated for the management of HIV infection. It helps in suppressing viral replication, controlling viral load, and supporting immune system health.
This combination works through multiple mechanisms: Lamivudine and Stavudine inhibit reverse transcriptase, while Nevirapine blocks viral replication at a different site. Together, they provide comprehensive viral suppression and improve long-term immune function in HIV-positive patients.
For distributors and healthcare suppliers, Lamicone NS Tablet is a high-demand ART product, widely prescribed by infectious disease specialists, HIV clinics, and hospitals. The growing need for effective HIV management ensures consistent market demand across urban and rural healthcare networks.
Adding Lamicone NS Tablet to your antiretroviral and viral suppression segment provides strong opportunities in pharmacies, HIV care centers, hospital supply chains, export markets, and third-party manufacturing. Its clinically proven efficacy, patient adherence profile, and broad therapeutic application make it a valuable addition for pharmaceutical distribution.
Common side effects may include headache, nausea, fatigue, diarrhea, or rash. Some patients may experience more serious adverse effects such as liver toxicity, lactic acidosis, peripheral neuropathy, or hypersensitivity reactions. Regular medical supervision is recommended to monitor for any severe or persistent symptoms.
Lamicone NS Tablet is indicated for the management of HIV-1 infection in adults and adolescents. It helps in suppressing viral replication, increasing CD4 cell counts, and delaying the onset of HIV-related complications. This combination therapy is often prescribed as part of antiretroviral treatment (ART) to achieve sustained viral suppression.
Before starting Lamicone NS Tablet, patients should inform their healthcare provider about any liver or kidney issues, existing infections, or allergies to medications. It is essential not to stop therapy abruptly, as this may lead to viral rebound and resistance. Periodic monitoring of liver function, kidney function, and viral load is advised during treatment.
Store Lamicone NS Tablet in a cool, dry place, away from direct sunlight and moisture. Keep the medication out of reach of children, and ensure the container is tightly sealed. Do not use the tablet beyond its expiration date.